Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma.

Nela Klein-Gonzalez, Udo Holtick, Kirsten Fairfax, Martin R Weihrauch, Michael S von Bergwelt-Baildon

Research output: Contribution to journalArticleOther

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)295 - 298
Number of pages4
JournalExpert Review of Vaccines
Issue number3
Publication statusPublished - 2011

Cite this